May 2015

Diagnologix was awarded a Phase II SBIR Grant "BUOYANCY BASED BIOSEPARATIONS" for the development of technology to isolate circulating tumor cells.

November 2014

Diagnologix was awarded a Phase I SBIR Grant, titled "AN INNOVATIVE SYSTEM FOR CORD BLOOD STEM CELL ISOLATION".

September 2014

Diagnologix was featured on Genomeweb.

September 2014

The Diagnologix team was accepted to the I-CorpsTM at NIH with a supplementary grant.

September 2013

Diagnologix was awarded a Phase I SBIR Grant Buoyancy Based Bioseparations for the development of technology to isolate circulating tumor cells.